Pedro Méndez
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Cancer Research top 5%
- Surgery top 10%
- Co-authors
- Miquel TarónJosé Javier SánchezRafael RosellCristina QueraltEnriqueta FelipJohn SouglakosJoaquim Majó FernándezJ Maestre
- Topics
- Cancer Genomics and Diagnostics (13 papers)Lung Cancer Treatments and Mutations (11 papers)RNA modifications and cancer (10 papers)
- Partner nations
- SpainUnited StatesPoland
In The Last Decade
Pedro Méndez
36 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 991
- Pulmonary and Respiratory Medicine 762
- Oncology 683
- Cancer Research 550
- Surgery 295
Countries citing papers authored by Pedro Méndez
This map shows the geographic impact of Pedro Méndez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Méndez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Méndez more than expected).
Fields of papers citing papers by Pedro Méndez
This network shows the impact of papers produced by Pedro Méndez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Méndez. The network helps show where Pedro Méndez may publish in the future.
Co-authorship network of co-authors of Pedro Méndez
This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Méndez. A scholar is included among the top collaborators of Pedro Méndez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Méndez. Pedro Méndez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 7 | |
| 3 | 7 | |
| 4 | 12 | |
| 5 | 0 | |
| 6 | 16 | |
| 7 | 9 | |
| 8 | 53 | |
| 9 | 84 | |
| 10 | 90 | |
| 11 | Expression of XPG mRNA and protein as potential biomarker of response to trabectedin in sarcoma patients | 2 |
| 12 | 29 | |
| 13 | 167 | |
| 14 | 145 | |
| 15 | 6 | |
| 16 | 5 | |
| 17 | 54 | |
| 18 | 72 | |
| 19 | 1 | |
| 20 | 6 |
About Pedro Méndez
Pedro Méndez is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 39 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (13 papers), Lung Cancer Treatments and Mutations (11 papers) and RNA modifications and cancer (10 papers). The work is most often cited by research in Cancer Research (550 citations), Oncology (683 citations) and Pulmonary and Respiratory Medicine (762 citations). Pedro Méndez has collaborated with scholars based in Spain, United States and Poland. Frequent co-authors include Miquel Tarón, José Javier Sánchez, Rafael Rosell, Rafael Rosell, Cristina Queralt, Enriqueta Felip, John Souglakos, Joaquim Majó Fernández, J Maestre and Fabiana Letizia Cecere. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.